Interventional Oncology Global Market Report 2022: Favourable Government Policies and Technological Advancements Drive Sector

Company Logo
Company Logo

Dublin, Dec. 02, 2022 (GLOBE NEWSWIRE) -- The "Interventional Oncology Market By Product: Global Opportunity Analysis and Industry Forecast, 2021-2031" report has been added to ResearchAndMarkets.com's offering.

The global interventional oncology market size is expected to reach up to $3,791.50 million by 2030, surging from $2,131.30 million in 2021, at a noteworthy CAGR of 6.5%.

Interventional oncology therapies are very beneficial for the patients as these therapies are minimally invasive, have lesser time for the recovery, have very few side effects as compared to other treatments, and involves lesser discomfort. Some of the interventional oncology operations can also be performed as an outpatient procedure, which allows the patient for earlier discharge which frees up hospital beds and lowers expenses, and this is expected to drive market growth. Nowadays, interventional oncology is considered as an important component in the field of modern oncology care, cancer treatment, supporting numerous surgical, medical, and radiation oncology therapies.

Rise in the volume of patients who are suffering from liver, breast, lung and other types of cancer, surge in the preferences towards minimally invasive procedures, rise in the prevalence of target and geriatric population, along with the rising levels of government support for interventional oncology and public-private funding, rise in the number of technological advancements are prevailing the growth of the interventional oncology market. Moreover, increasing number of applications from developing countries and rise in the number of hospitals which will further contribute by generating massive opportunities which are leading to the growth of the market. Along with this, the key players in the market are increasingly focusing on launching novel technologically advanced products.

However, scarcity of well-trained and oncologists and radiologists along with unfavorable regulations of the government are creating restraints in the interventional oncology market. Along with this, limited clinical data to support therapeutic efficacy along with prevalence of alternative therapies which will become the biggest and foremost challenge for the growth of the market.


Key Market Segments

By Product

  • Ablation

    • Radiofrequency Ablation Devices

    • Microwave Ablation Devices

    • Cryoablation Devices

    • Others

  • Particle Embolization

    • Radioembolic agents

    • Drug-Eluting Beads

    • Others

  • Support Devices

By Region

  • North America

  • U.S.

  • Canada

  • Mexico

  • Europe

  • Germany

  • France

  • UK

  • Italy

  • Spain

  • Rest of Europe

  • Asia-Pacific

  • Japan

  • China

  • Australia

  • India

  • South Korea

  • Taiwan

  • Rest of Asia-Pacific

  • LAMEA

  • Brazil

  • Turkey

  • Saudi Arabia

  • South Africa

  • Rest of LAMEA

Key Market Players

  • Alpinion Medical Systems Co. Ltd.

  • AngioDynamics

  • Boston Scientific Corporation

  • Hologic, Inc.

  • Medtronic Plc.

  • Merit Medical

  • Profound Medical

  • Siemens Healthineers

  • Teleflex Incorporated

  • Terumo Corporation

Key Findings of the Study

  • By product, the particle embolization segment currently dominates the global interventional oncology market and this trend is anticipated to continue during the forecast period owing to growing demand of embolization particles for interventional oncology and interventional cardiovascular procedure, and favorable reimbursement scenario.

  • On the basis of region, in 2021, North America dominated the market, owing to increasing expenditure on various cancer-related treatments and rise in the number of various state-of-the-art cancer care centers. However, Asia-Pacific is expected to witness considerable market growth during the forecast period due to its efforts taken up by the government to increase the funding for oncological treatments, commercialization of advanced interventional procedures and products along with the supportive regulations for development of these products, rising healthcare expenditure, and expansion of the research bases in countries like China, Japan, and India are fueling the growth of the market in this region.

Key Topics Covered:

CHAPTER 1: INTRODUCTION

CHAPTER 2: EXECUTIVE SUMMARY

CHAPTER 3: MARKET OVERVIEW

CHAPTER 4: INTERVENTIONAL ONCOLOGY MARKET, BY PRODUCT TYPE

CHAPTER 5: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE

CHAPTER 6: INTERVENTIONAL ONCOLOGY MARKET, BY END USER

CHAPTER 7: INTERVENTIONAL ONCOLOGY MARKET, BY REGION

CHAPTER 8: COMPANY LANDSCAPE

CHAPTER 9: COMPANY PROFILES

Companies Mentioned

  • Alpinion Medical Systems Co. Ltd.

  • Angiodynamics

  • Boston Scientific Corporation

  • Hologic, Inc.

  • Medtronic plc.

  • Merit Medical

  • Profound Medical

  • Siemens Healthineers

  • Teleflex Incorporated

  • Terumo Corporation

For more information about this report visit https://www.researchandmarkets.com/r/81i9dw

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900